Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

In a move to advance digital health technologies, the US Food and Drug Administration (FDA) has issued a Federal Register notice, “Prescription Drug-Use-Related Software” to seek early input from the public on the agency’s proposed framework for...

Allergan has decided not to pursue a $200-million expansion, first announced in 2016, at its manufacturing plant in Waco, Texas. Allergan had announced in 2016 plans to expand the Waco facility, which produces the company’s eye-care products,...

Moderna Therapeutics, a Cambridge, Massachusetts-based biotechnology company focusing on messenger RNA (mRNA) therapeutics, has filed a registration statement for an initial public offering with the US Securities and Exchange Commission with a...

ScieGen Pharmaceuticals, a Hauppauge, New York-based generic pharmaceutical company, is voluntarily recalling in the US lots of its irbesartan tablets (USP 75 mg, 150 mg, and 300 mg), an anti-hypertension drug, to the consumer level. The recall is...